An assessment of drug-induced rhabdomyolysis cases within the US Food and Drug Administration Adverse Event Reporting System

Bin Dayel Faten; Alfirevic Ana; Turner Richard; Chadwick Amy

首页> 外文期刊>British Journal of Clinical Pharmacology >An assessment of drug-induced rhabdomyolysis cases within the US Food and Drug Administration Adverse Event Reporting System

【24h】

An assessment of drug-induced rhabdomyolysis cases within the US Food and Drug Administration Adverse Event Reporting System

机译：评估美国食品和药物管理局内骨髓肌肉分解病例的评估不良事件报告系统

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《British Journal of Clinical Pharmacology》 |2021年第3期|共2页
作者
Bin Dayel Faten; Alfirevic Ana; Turner Richard; Chadwick Amy;
展开▼
作者单位

Univ Liverpool Liverpool Merseyside England;

Univ Liverpool Dept Pharmacol &

Therapeut Liverpool Merseyside England;

Univ Liverpool Dept Pharmacol &

Therapeut Liverpool Merseyside England;

Univ Liverpool Dept Pharmacol &

Therapeut Liverpool Merseyside England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. Analysis of Data on Adverse Drug Events Reported to the Food and Drugs Administration of the United States of America [J] . Emmanuel M. Baah 统计学期刊（英文） . 2020,第002期
2. Assessing taxane-associated adverse events using the FDA adverse event reporting system database [J] . Dong-Hui Lao, Ye Chen, Jun Fan, 中华医学杂志（英文版） . 2021,第012期
3. Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulators [J] . Kimberly A. Webster, Josephine Feliciano, Norah Lynn Henry, 癌症转移与治疗（英文版） . 2020,第003期
4. Levetiracetam‐induced rhabdomyolysis: Analysis of reports from the Food and Drug Administration's Adverse Event Reporting System database [J] . Carnovale Carla, Gentili Marta, Antoniazzi Stefania, Muscle and Nerve . 2017,第6期

机译：Levetiracetam诱导的横纹肌溶解：食品和药物管理局的不良事件报告系统数据库的报告分析
5. Rhabdomyolysis With Abiraterone Exposure: A Brief Review of the Food and Drug Administration Adverse Event Reporting System (FAERS) [J] . Moore Donald C., Ringley J. Tanner The annals of pharmacotherapy . 2018,第11期

机译：用Abiraatorone暴露的横纹肌分解：对食品和药物管理局的简要审查不良事件报告系统（FAE）
6. Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database [J] . Mazhar Faizan, Pozzi Marco, Gentili Marta, CNS drugs . 2019,第6期

机译：Hyponatraema和抗抑郁药物的协会：通过分析美国食品和药物管理副事件报告制度（FAES）数据库的药物检药 - 药学动力学评估
7. Analytic Scheme to Organize Large Archived Data into Hierarchical Affinity: A Case of Adverse Outcome Reports of the U.S. Food and Drug Administration Database [C] . Inki Kim, Gul E. Okudan Kremer Annual Conference and Expo of the Institute of Industrial Engineers . 2014

机译：分析方案将大型存档数据组织成分层亲和力：美国食品和药物管理局数据库的不利结果报告的情况
8. Study on impacts of promotion of generic drug utilization on spontaneous adverse event reports and drug safety assessment at the post-market stage [D] . TAKAMI, Akina 2019

机译：上市后阶段推广仿制药利用对自发不良事件报告和药物安全评估的影响
9. Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system [O] . Raymond K. Cross, Michael Chiorean, Francis Vekeman, 2019

机译：使用美国食品和药物管理局不良事件报告系统评估Vedolizumab的真实安全剖面
10. PHP92 Serious adverse Drug events reported to the Food and Drug Administration (FDA): analysis of the FDA adverse event reporting system (FAERS) 2006-2011 database [O] . Sonawane K.B., Hansen R.A. 2015

机译：PHP92向食品药品监督管理局（FDA）报告的严重不良药物事件：FDA不良事件报告系统（FAERS）2006-2011数据库的分析
11. Review of the Food and Drug Administration's Handling of Adverse Drug Reaction Reports. [R] . 1999

机译：审查食品和药物管理局处理药品不良反应报告。

An assessment of drug-induced rhabdomyolysis cases within the US Food and Drug Administration Adverse Event Reporting System

著录项

相似文献

相关主题

期刊订阅